Our Solutions   by Brands   K-Plast   Mabura 40 mg/0.8 ml Pen

Mabura 40 mg/0.8 ml Pen

Mabura 40 mg/0.8 mL Pen

*To be consumed as directed by physician.

Therapies:

Hepatitis, Rheumatology

Composition:

Adalimumab 40 mg/0.8 ml

About Mabura 40 mg/0.8 mL Pen

Mabura 40 mg/0.8 ml pen contains Adalimumab 40 mg, a monoclonal antibody that is classified in the class of tumour necrosis factor (TNF) alpha inhibitors. It is used to treat various autoimmune and inflammatory disorders by treating the underlying cause of inflammation rather than simply relieving symptoms. Mabura 40 pen helps reduce joint pain, stiffness, inflammation, ankylosing spondylitis, rheumatoid arthritis and Crohn’s disease. This pre-filled pen is recommended for subcutaneous use under medical supervision.

Mabura 40 mg/0.8 mL Pen

*To be consumed as directed by physician.


Usage Instructions

  • Use the Mabura 40 mg pen as prescribed by your physician.
  • It is normally given every other week via subcutaneous injection, while your physician may change the frequency according to the patient’s body response.
  • Do not change the dose or discontinue medication without consulting the physician, as inflammatory disorders may flare if therapy is interrupted.

    • Benefits and Use

  • Mabura 40 mg Pen relieves symptoms of several chronic inflammatory diseases by blocking TNF-alpha, the protein that drives swelling, pain, and joint damage.
  • It's used to manage rheumatoid arthritis, ankylosing spondylitis, psoriasis, Crohn's disease, and ulcerative colitis, helping restore mobility and improve the quality of life of patients.

    • Safety Information

  • Pregnancy
  • Mabura 40 Pen should be used during pregnancy only if clearly recommended by your physician after evaluating the potential benefits and risks. Inform your physician if you are pregnant or planning to conceive.
  • Breastfeeding
  • Breastfeeding mothers should inform their physician before starting Adalimumab. Although small amounts of the medicine may pass into breast milk, your physician will assess the benefits and potential risks before recommending whether to continue treatment or breastfeeding.
  • Alcohol
  • Alcohol consumption is not recommended, particularly if you have liver disease or are taking other medications.
  • Kidney Disorders
  • Dose adjustment is generally required in patients with kidney impairment. Inform your doctor about any existing kidney condition so your health can be monitored appropriately during treatment.
  • Liver Disorders
  • Patients with liver disease should use Mabura 40 Pen cautiously under medical supervision. Your physician may suggest regular liver function monitoring throughout the course, especially if you have pre-existing liver conditions.

    • Precautions

    Store in a refrigerator (2 - 8°C). Do not freeze.

    Ingredients

    Adalimumab 40 mg

    How to Administer

    A healthcare professional will administer Mabura 40 mg/0.8 ml Pen. Do not self-administer. Follow your doctor’s instructions for safe use.

    How to Use

  • Mabura 40 mg pen should be given by a certified physician to the patient after evaluating the risks and benefits.
  • Do not self-administer Mabura 40 mg/0.8 ml pen without proper guidance from your physician.

    • Storage Information

    Mabura 40 pen should be refrigerated between 2°C and 8°C. Do not freeze or shake the pen.